These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 18805675)
1. Evidence for the presence of R250G mutation at the ATPase domain of topoisomerase II in an arsenite-resistant Leishmania donovani exhibiting a differential drug inhibition profile. Singh G; Thakur M; Chakraborti PK; Dey CS Int J Antimicrob Agents; 2009 Jan; 33(1):80-5. PubMed ID: 18805675 [TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis-like cell death by pentamidine and doxorubicin through differential inhibition of topoisomerase II in arsenite-resistant L. donovani. Singh G; Dey CS Acta Trop; 2007 Sep; 103(3):172-85. PubMed ID: 17655815 [TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of wild type and arsenite-resistant Leishmania donovani. Sharma S; Singh G; Chavan HD; Dey CS Exp Parasitol; 2009 Dec; 123(4):369-76. PubMed ID: 19679130 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide. Sengupta T; Mukherjee M; Das A; Mandal C; Das R; Mukherjee T; Majumder HK Biochem J; 2005 Sep; 390(Pt 2):419-26. PubMed ID: 15901238 [TBL] [Abstract][Full Text] [Related]
7. Overexpression and increased DNA topoisomerase II-like enzyme activity in arsenite resistant Leishmania donovani. Jayanarayan KG; Dey CS Microbiol Res; 2003; 158(1):55-8. PubMed ID: 12608580 [TBL] [Abstract][Full Text] [Related]
8. Resistance to arsenite modulates expression of beta- and gamma-tubulin and sensitivity to paclitaxel during differentiation of Leishmania donovani. Jayanarayan KG; Dey CS Parasitol Res; 2002 Aug; 88(8):754-9. PubMed ID: 12122434 [TBL] [Abstract][Full Text] [Related]
9. Two distinct arsenite-resistant variants of Leishmania amazonensis take different routes to achieve resistance as revealed by comparative transcriptomics. Lin YC; Hsu JY; Shu JH; Chi Y; Chiang SC; Lee ST Mol Biochem Parasitol; 2008 Nov; 162(1):16-31. PubMed ID: 18674569 [TBL] [Abstract][Full Text] [Related]
10. Putative P-glycoprotein expression in arsenite-resistant Leishmania donovani down-regulated by verapamil. Kaur J; Dey CS Biochem Biophys Res Commun; 2000 May; 271(3):615-9. PubMed ID: 10814510 [TBL] [Abstract][Full Text] [Related]
11. Distinct overexpression of cytosolic and mitochondrial tryparedoxin peroxidases results in preferential detoxification of different oxidants in arsenite-resistant Leishmania amazonensis with and without DNA amplification. Lin YC; Hsu JY; Chiang SC; Lee ST Mol Biochem Parasitol; 2005 Jul; 142(1):66-75. PubMed ID: 15907561 [TBL] [Abstract][Full Text] [Related]
12. Altered expression, polymerisation and cellular distribution of alpha-/beta-tubulins and apoptosis-like cell death in arsenite resistant Leishmania donovani promastigotes. Jayanarayan KG; Dey CS Int J Parasitol; 2004 Jul; 34(8):915-25. PubMed ID: 15217730 [TBL] [Abstract][Full Text] [Related]
13. Confocal microscopic investigation of tubulin distribution and effect of paclitaxel on posttranslationally modified tubulins in sodium arsenite resistant Leishmania donovani. Chavan HD; Singh G; Dey CS Exp Parasitol; 2007 Jul; 116(3):320-6. PubMed ID: 17367783 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo. Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445 [TBL] [Abstract][Full Text] [Related]
15. Topoisomerase I amino acid substitutions, Gly185Arg and Asp325Glu, confer camptothecin resistance in Leishmania donovani. Marquis JF; Hardy I; Olivier M Antimicrob Agents Chemother; 2005 Apr; 49(4):1441-6. PubMed ID: 15793124 [TBL] [Abstract][Full Text] [Related]
16. Leishmania donovani bisubunit topoisomerase I gene fusion leads to an active enzyme with conserved type IB enzyme function. Das BB; Bose Dasgupta S; Ganguly A; Mazumder S; Roy A; Majumder HK FEBS J; 2007 Jan; 274(1):150-63. PubMed ID: 17222179 [TBL] [Abstract][Full Text] [Related]
17. An insight into the mechanism of inhibition of unusual bi-subunit topoisomerase I from Leishmania donovani by 3,3'-di-indolylmethane, a novel DNA topoisomerase I poison with a strong binding affinity to the enzyme. Roy A; Das BB; Ganguly A; Bose Dasgupta S; Khalkho NV; Pal C; Dey S; Giri VS; Jaisankar P; Dey S; Majumder HK Biochem J; 2008 Jan; 409(2):611-22. PubMed ID: 17922678 [TBL] [Abstract][Full Text] [Related]
18. Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy. Das A; Dasgupta A; Sharma S; Ghosh M; Sengupta T; Bandopadhyay S; Majumder HK Nucleic Acids Res; 2001 May; 29(9):1844-51. PubMed ID: 11328867 [TBL] [Abstract][Full Text] [Related]
19. Prokaryotic expression, purification, and polyclonal antibody production against a novel drug resistance gene of Leishmania donovani clinical isolate. Kothari H; Kumar P; Singh N Protein Expr Purif; 2006 Jan; 45(1):15-21. PubMed ID: 16289919 [TBL] [Abstract][Full Text] [Related]
20. Arsenite-resistant Leishmania donovani promastigotes express an enhanced membrane P-type adenosine triphosphatase activity that is sensitive to verapamil treatment. Prasad V; Kaur J; Dey CS Parasitol Res; 2000 Aug; 86(8):661-4. PubMed ID: 10952266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]